Skip to main content
. 2021 Feb 22;15:721–733. doi: 10.2147/DDDT.S288859

Figure 1.

Figure 1

Clinical progression of miRNA drug and siRNA drug. (A) The number of miRNA drugs and siRNA drugs in different clinical periods (terminated/suspended, phase I, phase II, phase III, approved). (B) The ratio of miRNA drugs and siRNA drugs of different clinical periods.